This EpiPen Competitor Will Be Launching Next Month
Author By Sophia VidaPosted on A company called Kaleo made a huge announcement on Thursday that could have EpiPen maker Mylan feeling pretty nervous right now.
Kaleo announced that a major competitor to the EpiPen will be launching on February 14th for $360 for a two pack.
Mylan had increased the price of their EpiPen to $609 for a two pack months ago, stirring some major backlash. The company launched an authorized generic version for $300 for a two pack in late 2016 as a result.
According to Kaleo, this new competitor, called Auvi-Q, will be free to patients with commercial insurance — even if they have a high deductible plan.
Looks like Mylan’s monopoly days for this life-saving allergy injection may soon be over.
Disclaimer: We have no position in Mylan Inc. (NASDAQ: MYL) and have not been compensated for this article.
